The Department of Science and Technology (DOST) has explained why the country’s eight month-long clinical trial seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in...
The Department of Science and Technology (DOST) said the “latest protocol" for the country’s eight month-long clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients...
The Department of Science and Technology (DOST) said Sunday, Oct. 31, that the eight month-long clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in...
The Department of Science and Technology (DOST) said Saturday, Oct. 23, said the recruitment of over 1,400 participants for the eight month-long clinical Ivermectin clinical trials is expected to start in November, and that the initial results of the study may be out by end of December this year....
Bracing for “good results,” the Department of Science and Technology (DOST) said Thursday, Oct. 21, that the drug developers and the public are expected to benefit from the country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug...
The country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in isolation facilities will begin on Oct. 15, the Department of Science and Technology...
The clinical trial on the use of anti-parasitic drug Ivermectin for COVID-19 patients in the country has been moved again for one more month, from Sept. 15 to Oct. 15, due to ongoing revisions on its protocols. Department of Science and Technology (DOST) Sec. Fortunato Dela Peña said in a...
The country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) is set to begin on Sept. 15, the Department of Science and Technology (DOST) said Friday, Aug. 27. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and...
The Department of Science and Technology (DOST) said Thursday, Aug. 19, that the changes to clinical trial protocols have delayed the start of the country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) in the country....
The clinical trials on the use of Ivermectin as a treatment for coronavirus disease (COVID-19) will begin next month, the Department of Science and Technology (DOST) said on Wednesday, Aug. 18. (MANILA BULLETIN FILE PHOTO) DOST Secretary Fortunato “Boy” T. de la Peña said the eight month-long...
The clinical trials on the use of Ivermectin as a treatment for coronavirus disease (COVID-19) will start next month. (MANILA BULLETIN FILE PHOTO) The Department of Science and Technology- Philippine Council for Health Research and Development (DOST-PCHRD) said Friday, July 23, that the eight...
The Philippines is now part of an international consortium that is conducting an analysis of all the randomized Ivermectin clinical trials around the world, the Department of Science and Technology (DOST) announced on Friday, June 25. (MANILA BULLETIN FILE PHOTO) DOST Secretary Fortunato “Boy”...
